Orr W M, Jackson W B, Colden K
Can J Ophthalmol. 1985 Aug;20(5):171-5.
The intraocular penetration of the aminoglycoside netilmicin following intramuscular and subconjunctival injection was studied in 102 patients undergoing elective cataract surgery. Those who received either a single 1.5-mg/kg intramuscular injection or two 1.5-mg/kg injections 6 hours apart subsequently had therapeutic serum levels but aqueous levels of less than 2.4 micrograms/mL. Those who received a subconjunctival injection of either 12.5 or 25 mg of netilmicin subsequently had aqueous levels of up to 36 or 85.6 micrograms/mL; therapeutic levels in the anterior chamber persisted for 7 to 9 hours, with higher levels following the 25-mg injection. Despite wide variation in the aqueous levels following subconjunctival injection the ocular penetration of netilmicin was comparable to that reported for other aminoglycosides. No major complications were associated with the use of this antibiotic by either route.
在102例择期白内障手术患者中,研究了氨基糖苷类药物奈替米星经肌肉注射和结膜下注射后的眼内穿透情况。接受单次1.5mg/kg肌肉注射或两次间隔6小时的1.5mg/kg注射的患者,随后血清水平达到治疗浓度,但房水浓度低于2.4μg/mL。接受12.5mg或25mg奈替米星结膜下注射的患者,随后房水浓度分别高达36μg/mL或85.6μg/mL;前房内的治疗浓度持续7至9小时,25mg注射后的浓度更高。尽管结膜下注射后的房水浓度差异很大,但奈替米星的眼内穿透情况与其他氨基糖苷类药物的报告相当。两种给药途径使用这种抗生素均未出现重大并发症。